» Articles » PMID: 27683600

Molecular Imaging of Angiogenesis in Cardiac Regeneration

Overview
Publisher Springer
Date 2016 Sep 30
PMID 27683600
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Myocardial infarction (MI) leading to heart failure displays an important cause of death worldwide. Adequate restoration of blood flow to prevent this transition is a crucial factor to improve long-term morbidity and mortality. Novel regenerative therapies have been thoroughly investigated within the past decades.

Recent Findings: Increased angiogenesis in infarcted myocardium has shown beneficial effects on the prognosis of MI; therefore, the proangiogenic capacity of currently tested treatments is of specific interest. Molecular imaging to visualize formation of new blood vessels in vivo displays a promising option to monitor proangiogenic effects of regenerative substances.

Summary: Based on encouraging results in preclinical models, molecular angiogenesis imaging has recently been applied in a small set of patients. This article reviews recent literature on noninvasive in vivo molecular imaging of angiogenesis after MI as an integral part of cardiac regeneration.

Citing Articles

Increased [F]FDG uptake in the infarcted myocardial area displayed by combined PET/CMR correlates with snRNA-seq-detected inflammatory cell invasion.

Lukovic D, Gyongyosi M, Pavo I, Mester-Tonczar J, Einzinger P, Zlabinger K Basic Res Cardiol. 2024; 119(5):807-829.

PMID: 38922408 PMC: 11461641. DOI: 10.1007/s00395-024-01064-y.


[Ga]Ga-NODAGA-E[(cRGDyK)] and [Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy.

Follin B, Hoeeg C, Hunter I, Bentsen S, Juhl M, Jensen J Diagnostics (Basel). 2023; 13(2).

PMID: 36673078 PMC: 9857952. DOI: 10.3390/diagnostics13020268.


Nuclear Molecular Imaging of Cardiac Remodeling after Myocardial Infarction.

Varasteh Z, Weber W, Rischpler C Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215296 PMC: 8875369. DOI: 10.3390/ph15020183.


Multi-Scale Imaging of Vascular Pathologies in Cardiovascular Disease.

Tiwari A, Elgrably B, Saar G, Vandoorne K Front Med (Lausanne). 2022; 8:754369.

PMID: 35071257 PMC: 8766766. DOI: 10.3389/fmed.2021.754369.


Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure.

Balogh V, MacAskill M, Hadoke P, Gray G, Tavares A Front Cardiovasc Med. 2021; 8():719031.

PMID: 34485416 PMC: 8416043. DOI: 10.3389/fcvm.2021.719031.


References
1.
Frangogiannis N . The mechanistic basis of infarct healing. Antioxid Redox Signal. 2006; 8(11-12):1907-39. DOI: 10.1089/ars.2006.8.1907. View

2.
Zhang Y, Hong H, Severin G, Engle J, Yang Y, Goel S . ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. Am J Transl Res. 2012; 4(3):333-46. PMC: 3426387. View

3.
Cohn J, Ferrari R, Sharpe N . Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000; 35(3):569-82. DOI: 10.1016/s0735-1097(99)00630-0. View

4.
Menichetti L, Kusmic C, Panetta D, Arosio D, Petroni D, Matteucci M . MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction. Eur J Nucl Med Mol Imaging. 2013; 40(8):1265-74. DOI: 10.1007/s00259-013-2432-9. View

5.
Gaemperli O, Kaufmann P, Alkadhi H . Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging. 2014; 41 Suppl 1:S91-103. DOI: 10.1007/s00259-013-2566-9. View